Lexicon Pharmaceuticals
Home
Contact Us
Site Map
About Us
About Us Home
Management Team
Board of Directors
Development Team
Locations
Contact Us
History
Pipeline
Drug Pipeline Home
Our Goal
Therapeutic Areas
Drug Development Team
Clinical Trials
Publications
Discovery
Discovery Home
Discovery Process
Technology
Genome5000
Medicinal Chemistry
Patents
Academic Access
Technology Licensing
Scientific Publications
Alliances
Alliances Home
Current Alliances
Technology Licensing
Careers
Careers Home
Opportunities
Our Culture
Benefits
Community Involvement
The Woodlands
Princeton
Awards and Recognition
News
News Home
Media Inquiries
Investors
Investors Home
Media
Events
Stock Quote
SEC Filings
Annual Reports
Corporate Governance
Request Information
News Home
Media Inquiries
Subscribe
Press Releases
Filter
Display #
5
10
15
20
25
30
50
100
All
06/17/2007
Lexicon Pharmaceuticals Announces Two Agreements to Finance Long-Term Drug Development Strategy
06/08/2007
Lexicon Pharmaceuticals and Fox Chase Publish Findings on Immune Deficiency
06/07/2007
Lexicon Pharmaceuticals to Present at the Needham Biotechnology & Medical Technology Conference
05/23/2007
Lexicon Pharmaceuticals to Present at the Bank of America Health Care Conference
05/15/2007
Lexicon Pharmaceuticals Named One of the Best Places to Work by The Scientist
05/07/2007
Lexicon to Present at the BIO 2007 International Convention
05/01/2007
Lexicon Pharmaceuticals Reports 2007 First Quarter Financial Results
04/26/2007
Lexicon Genetics Changes Name to Lexicon Pharmaceuticals as Drug Development Pipeline Progresses
04/24/2007
Lexicon Advances LX1031 for Irritable Bowel Syndrome into Phase 1b Clinical Trial
04/23/2007
Lexicon to Present at the Morgan Stanley Global Healthcare Unplugged Conference
«
Start
Prev
1
2
3
4
5
6
7
8
9
10
Next
End
»
Page 10 of 37